Hua Medicine (the “Company”, HKEx stock code: 2552) announced today that the Company has successfully completed a Phase I clinical trial on its 2nd generation GKA candidate in U.S. at the 9th China ...
The management of bone and joint infections has long relied on intravenous (IV) antibiotics. Still, emerging evidence ...
The mouth and the whole body are but one system, they cannot exist otherwise, paying attention to your oral health has a ...
Most patients still need to be managed by oral medications to treat diabetes and not injections, at least in the early stages ...
The publisher has been closely monitoring the various markets in Saudi Arabia Diabetes Devices and Therapeutics Business Market. This report provides a comprehensive analysis, detailing market size, ...
With expected sales for GLP1Rs in obesity estimated to surpass $126 billion by 2030, this drug category presents a lucrative ...
'Non-oral migraine medications, such as injectables and nasal sprays, do not rely on the digestive system to be absorbed and can offer the potential for faster relief from migraine symptoms in as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback